Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been linked to a higher risk of mortality compared to influenza, which is mainly due to severe secondary diseases, such as acute respiratory distress syndrome (ARDS). In turn, ARDS is characterized by an acute inflammation and an excessive activity of the coagulation cascade...
Alternative Titles
Full title
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_469928
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_469928
Other Identifiers
ISSN
0929-5305
E-ISSN
1573-742X
DOI
10.1007/s11239-020-02212-6
